「ac」の検索結果
129件：21～25件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
General Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr....
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
BREN5_TE_C2_20220802
xime Hydrochloride） 〔JAN〕 略 号：CMX 化学名： （ , ） -7- ［ （ ） -2- （2-Aminothiazol-4-yl） -2- （methoxyimino） acetylamino]-3- （1-methyl-1 -tetrazol- 5-ylsulfanylmethyl） -8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-e...
https://www.senju.co.jp/system/files/product_other_file/2022-09/BREN5_TE_C2_20221101.pdf -
July 16, 2024 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease tr...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf